PET-based Imaging Improves Metastases Detection in Biochemically Recurrent Prostate Cancer PET-based Imaging Improves Metastases Detection in Biochemically Recurrent Prostate Cancer

Gallium-68 prostate-specific membrane antigen positron emission tomography (Ga-68 PSMA PET) accurately detects metastases in biochemically recurrent prostate cancer, particularly at low prostate-specific antigen (PSA) levels, researchers say.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news